TLSA שווי כולל של נכסי החברה Tiziana Life Sciences Ltd.
The price action for Tiziana Life Sciences (TLSA) on the GURU.Markets platform, where total assets amount to 14.13, indicates a business whose prospects depend on the success of immunotherapy for neurodegenerative pathologies, patents, and investments. Tiziana Life Sciences provides complex temperature-controlled antibody transport, minimizing customs risks. Meanwhile, capital is entirely absorbed by clinical trial costs, which temporarily precludes margin growth.
פילוחים אנליטיים ודוחות נתונים של חברת Tiziana Life Sciences PLC (TLSA)
Total assets determine the aggregate value of a company's resources, combining equity and liabilities to assess the scale of the business. By analyzing the trajectory of all corporate resources, an investor can perform a reverse calculation via ROA, which reveals the extent to which balance sheet growth depends on the quality of collateral coverage. This metric allows for the tracking of the risk of inflated liabilities in the absence of real security. For Tiziana Life Sciences (TLSA), this indicator reflects the financing efficiency of costly clinical trials for neurodegenerative drugs.